The modulatory role of heme oxygenase on subpressor angiotensin II-induced hypertension and renal injury

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Chandrashekar, Kiran ^a   Lopez Ruiz, Arnaldo ^a   Juncos, Ramiro ^a   Nath, Karl ^b   Stec, David E ^a   Vera, Trinity ^a   Liu, Ruisheng ^a   Juncos, Luis A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; HEME OXYGENASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN TIN; SUBPRESSOR ANGIOTENSIN II; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MARKER; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REGULATORY MECHANISM; RENAL PROTECTION;

EID: 84868288218     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/392890     Document Type: Article

References (20)

1. Aizawa T., Ishizaka N., Taguchi J. I., Nagai R., Mori I., Tang S. S., Ingelfinger J. R., Ohno M., Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 2000 35 3 800 806 2-s2.0-0034065989 (Pubitemid 30165329)
2. Haugen E. N., Croatt A. J., Nath K. A., Angiotensin ii induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney International 2000 58 1 144 152 2-s2.0-0033922326 10.1046/j.1523-1755.2000. 00150.x (Pubitemid 30429859)
3. Abraham N. G., Kappas A., Pharmacological and clinical aspects of heme oxygenase. Pharmacological Reviews 2008 60 1 79 127 2-s2.0-46949108047 (Pubitemid 351439218)
4. Hood S. G., Cochrane T., McKinley M. J., May C. N., Investigation of the mechanisms by which chronic infusion of an acutely subpressor dose of angiotensin II induces hypertension. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2007 292 5 R1893 R1899 2-s2.0-34248194250 10.1152/ajpregu.00803.2006 (Pubitemid 46708544)
5. Simon G., Abraham G., Cserep G., Pressor and subpressor angiotensin II administration. Two experimental models of hypertension. American Journal of Hypertension 1995 8 6 645 650 2-s2.0-0029025359 10.1016/0895-7061(95)00047-S
6. Wu W., Zhang Y., Ballew J. R., Fink G., Wang D. H., Development of hypertension induced by subpressor infusion of angiotensin II: role of sensory nerves. Hypertension 2000 36 4 549 552 2-s2.0-0033778589
7. Rajagopalan S., Kurz S., Münzel T., Tarpey M., Freeman B. A., Griendling K. K., Harrison D. G., Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. Journal of Clinical Investigation 1996 97 8 1916 1923 2-s2.0-0030005713
8. Ortiz M. C., Sanabria E., Manriquez M. C., Romero J. C., Juncos L. A., Role of endothelin and isoprostanes in slow pressor responses to angiotensin II. Hypertension 2001 37 2 505 510 2-s2.0-0035093163 (Pubitemid 32199019)
9. Pelaez L. I., Manriquez M. C., Nath K. A., Romero J. C., Juncos L. A., Low-dose angiotensin II enhances pressor responses without causing sustained hypertension. Hypertension 2003 42 4 798 801 2-s2.0-0141893586 10.1161/01.HYP.0000085782.99773.B6 (Pubitemid 37237328)
10. Brown A. J., Casals-Stenzel J., Gofford S., Lever A. F., Morton J. J., Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. The American journal of physiology 1981 241 3 H381 388 2-s2.0-0019614763
11. Nath K. A., Hernandez M. C., Croatt A. J., Katusic Z. S., Juncos L. A., Heme oxygenase activity as a determinant of the renal hemodynamic response to low-dose ANG II. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2010 299 5 R1183 R1191 2-s2.0-78149474272 10.1152/ajpregu.00212.2010
12. Ronco C., Chionh C. Y., Haapio M., Anavekar N. S., House A., Bellomo R., The cardiorenal syndrome. Blood Purification 2009 27 1 114 126 2-s2.0-58849091322 10.1159/000167018
13. Zager R. A., Baltes L. A., Sharma H. M., Jurkowitz M. S., Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney International 1984 26 5 689 700 2-s2.0-0021720246 (Pubitemid 15216140)
14. Vera T., Kelsen S., Yanes L. L., Reckelhoff J. F., Stec D. E., HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2007 292 4 R1472 R1478 2-s2.0-34147153226 10.1152/ajpregu.00601.2006 (Pubitemid 46557809)
15. Rosenberg M. E., Smith L. J., Correa-Rotter R., Hostetter T. H., The paradox of the renin-angiotensin system in chronic renal disease. Kidney International 1994 45 2 403 410 2-s2.0-0028157391 (Pubitemid 24065073)
16. Anderson S., Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat. Mineral and Electrolyte Metabolism 1998 24 6 406 411 2-s2.0-0032443625 10.1159/000057402 (Pubitemid 29056251)
17. Lafayette R. A., Mayer G., Park S. K., Meyer T. W., Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. Journal of Clinical Investigation 1992 90 3 766 771 2-s2.0-0026657559
18. Aizawa T., Ishizaka N., Kurokawa K., Nagai R., Nakajima H., Taguchi J. I., Ohno M., Different effects of angiotensin II and catecholamine on renal cell apoptosis and proliferation in rats. Kidney International 2001 59 2 645 653 2-s2.0-0035132559 10.1046/j.1523-1755.2001.059002645.x (Pubitemid 32157929)
19. Johnson F. K., Johnson R. A., Durante W., Jackson K. E., Stevenson B. K., Peyton K. J., Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2006 290 3 R601 R608 2-s2.0-33645399764 10.1152/ajpregu.00308.2005
20. Bolignano D., Lacquaniti A., Coppolino G., Donato V., Campo S., Fazio M. R., Nicocia G., Buemi M., Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clinical Journal of the American Society of Nephrology 2009 4 2 337 344 2-s2.0-66849091695 10.2215/CJN.03530708